Illumina Balance Sheet Health
Financial Health criteria checks 3/6
Illumina has a total shareholder equity of $2.1B and total debt of $2.0B, which brings its debt-to-equity ratio to 93.6%. Its total assets and total liabilities are $6.0B and $3.9B respectively. Illumina's EBIT is $338.0M making its interest coverage ratio 7.3. It has cash and short-term investments of $939.0M.
Key information
93.6%
Debt to equity ratio
US$1.99b
Debt
| Interest coverage ratio | 7.3x |
| Cash | US$939.00m |
| Equity | US$2.13b |
| Total liabilities | US$3.89b |
| Total assets | US$6.01b |
Recent financial health updates
We Think Illumina (NASDAQ:ILMN) Can Stay On Top Of Its Debt
Oct 21
Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14Recent updates
Illumina: Q3 Confirms Improving Fundamentals
Nov 05We Think Illumina (NASDAQ:ILMN) Can Stay On Top Of Its Debt
Oct 21Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)
Aug 21Illumina: Strengthening Competitive Position, Relevance And A Very Compelling Valuation
Jul 23Illumina, Inc.'s (NASDAQ:ILMN) Share Price Could Signal Some Risk
Jul 01Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out
Jun 28Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$106?
May 26Illumina: Expect A Slow Rebound
May 07Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)
Apr 26Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)
Mar 20Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
Feb 23Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024
Jan 19Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%
Dec 21Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
Dec 03Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?
Oct 03At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?
Aug 22The Big Trends: New Frontiers in Healthcare
Jul 13
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Jul 03Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Apr 12Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14Financial Position Analysis
Short Term Liabilities: ILMN's short term assets ($2.4B) exceed its short term liabilities ($975.0M).
Long Term Liabilities: ILMN's short term assets ($2.4B) do not cover its long term liabilities ($2.9B).
Debt to Equity History and Analysis
Debt Level: ILMN's net debt to equity ratio (49.4%) is considered high.
Reducing Debt: ILMN's debt to equity ratio has increased from 25.5% to 93.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable ILMN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: ILMN is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 28.3% per year.